Create Account | Sign In: Author or Forum

                                      Search Symptoms

                                      Medical Specialty >>


                                      1:03 PM CDT. Read article More News

                                      JOURNAL UPDATE

                                      Home Hazard Removal Program Cuts Rate of Falls Among Elderly

                                      7:46 PM CDT.

                                      While the program did not reduce the hazard of falls, authors say it nonetheless may be an important,…

                                      MONTHLY JOURNAL SUMMARY

                                      September 2020 Briefing - Pharmacy

                                      October 01, 2020. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.

                                      FEATURED ARTICLES

                                      Immunotherapy with Checkpoint Inhibitors in Triple Negative Breast Cancer (TNBC)

                                      Karima Oualla, MD. Dr. Karima Oualla discusses recent advances on the use of checkpoint inhibitors in the treatment of triple negative breast cancer (TNBC). Dr. Oualla is an International expert in breast cancer and is the primary author of the manuscript entitled "Novel therapeutic strategies in the treatment of triple-negative…

                                      Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial

                                      Robert L. Coleman, MD. Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…

                                      Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

                                      Ted Lain, MD. Clinical trial investigator Dr. Ted Lain ments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…

                                      MEDICAL FOCUS

                                      Acute dyspnea (shortness of breath)

                                      By Tamer M. Fouad, M.D.

                                      Dyspnea (shortness of breath) is a term used to characterize a subjective experience of breathing disfort that is prised of qualitatively distinct…


                                      RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

                                      By namabc

                                      As I understand, this is a great step of development that we can use to save many people from horrible diseases. and i also hope Dr.Lain and your partners…


                                      Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website

                                      Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.


                                                                                                    日韩欧无码中文字幕在线看 韩国美女一级黄色视频 UUav在线观看 Javlibrary hjd1024 黄片,毛片A级免费看